Human Parvovirus B19 Antibodies Are Less Frequent among Patients Treated with Factor IX Concentrate Inactivated by Ultrafiltration: A Report from a Single Spanish Institution

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Vox sanguinis 1998-06, Vol.74 (4), p.260-261
Hauptverfasser:	Canales, Miguel A., Pinilla, Javier, Mateos, Pablo, Martinez Zapico, Rosa, Alvarez, Teresa, Jiménez, Victor M., Quintana, Manuel, Villar, Ana, Hernández Navarro, Fernando, Magallón, Manuel
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Antibodies, Viral - blood Biological and medical sciences Blood. Blood and plasma substitutes. Blood products. Blood cells. Blood typing. Plasmapheresis. Apheresis Child Child, Preschool Coagulation Protein Disorders - therapy Factor IX - adverse effects Factor IX - therapeutic use Humans Infant Medical sciences Middle Aged Parvoviridae Infections - epidemiology Parvoviridae Infections - etiology Parvoviridae Infections - immunology Parvovirus B19, Human - immunology Prevalence Spain - epidemiology Transfusions. Complications. Transfusion reactions. Cell and gene therapy Ultrafiltration
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!